NCT06753136 Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype Status RECRUITING Phase NA
NCT06747390 Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery Status RECRUITING Phase PHASE1
NCT06731933 Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin Status RECRUITING Phase PHASE2
NCT06615635 Clinical Study Protocol for Cutaneous SCC for Immunocompromised Patients Status NOT_YET_RECRUITING Phase NA
NCT06609070 CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC Status NOT_YET_RECRUITING Phase NA
NCT06450080 Study of the Relationship Between Clinical, Imaging and Biological Data in Patients With Squamous Cell Carcinoma of the Tongue Status RECRUITING Phase NA
NCT06418516 Early Detection of Esophageal Squamous Cancer With the Capsule Sponge Device Status NOT_YET_RECRUITING Phase NA
NCT06047379 Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis Status RECRUITING Phase PHASE1/PHASE2
NCT06046625 Needs and Preferences of Patients With Head-neck Cutaneous SCC Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06041802 A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05987579 Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05974410 Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients Status AVAILABLE Phase N/A
NCT05932511 Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer Status UNKNOWN Phase EARLY_PHASE1
NCT05929547 Patient Perspectives in Squamous Cell Carcinoma Clinical Trials Status NOT_YET_RECRUITING Phase N/A